Equiloid InnovatorThis page contains information on Equiloid Innovator for veterinary use.
The information provided typically includes the following:
- Equiloid Innovator Indications
- Warnings and cautions for Equiloid Innovator
- Direction and dosage information for Equiloid Innovator
Equiloid InnovatorThis treatment applies to the following species:
Eastern & Western, Killed Virus
This product has been shown to be effective for the vaccination of healthy horses 10 months of age or older against encephalomyelitis caused by Eastern and Western viruses, and tetanus. Duration of immunity has not been established. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.
Field safety testing has demonstrated that this product is safe for use in horses 3 months of age or older. Efficacy has not been established in foals 3 months of age. Safe for administration of one dose during the third trimester of pregnancy.
Directions For Use
Shake well. Aseptically administer 1 mL intramuscularly. Healthy horses should receive two doses administered 3-4 weeks apart. For advice on revaccination frequency or in the face of stress or exposure, contact your veterinarian or the manufacturer.
PrecautionsStore at 2°-8°C. Prolonged exposure to higher temperatures and/or direct sunlight may adversely affect potency. Do not freeze. Use entire contents when first opened. Transient local reactions may occur at the injection site. Do not vaccinate within 21 days before slaughter. Contains formalin, thimerosal, neomycin, and polymyxin B as preservatives. Do not mix with other products. In case of human exposure, contact a physician.
Technical inquiries should be directed to Zoetis Inc. Veterinary Services, (888) 963-8471.
Remove serial number and expiration date label and place on the animal’s medical chart.
VLN 190/PCN 4865.28
Zoetis Inc., Kalamazoo, MI 49007, USA
333 PORTAGE STREET, KALAMAZOO, MI, 49007
Copyright © 2023 Animalytix LLC. Updated: 2023-05-30